Evidence map›Paper›PMID 34681261›Full record

ArticlePharmaceuticals (Basel, Switzerland)2021

Thermodynamic Study of Oxidovanadium(IV) with Kojic Acid Derivatives: A Multi-Technique Approach.

Rosita Cappai, Guido Crisponi, Daniele Sanna, Valeria Ugone, Andrea Melchior, Eugenio Garribba, Massimiliano Peana, Maria Antonietta Zoroddu, Valeria Marina Nurchi

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Fungal production of kojic acid and its industrial applications.Applied microbiology and biotechnology · 2023
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rosita CappaiDipartimento di Scienze della Vita e dell'Ambiente, Università di Cagliari, 09042 Cagliari, Italy.ORCID 0000-0002-6544-8311
Guido CrisponiDipartimento di Scienze della Vita e dell'Ambiente, Università di Cagliari, 09042 Cagliari, Italy.ORCID 0000-0002-3902-0231
Daniele SannaIstituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Trav. La Crucca 3, 07100 Sassari, Italy.ORCID 0000-0001-9299-0141
Valeria UgoneIstituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Trav. La Crucca 3, 07100 Sassari, Italy.ORCID 0000-0002-2830-3869
Andrea MelchiorDPIA, Laboratorio di Scienze e Tecnologie Chimiche, Università di Udine, Via del Cotonificio 108, 33100 Udine, Italy.ORCID 0000-0002-5265-1396
Eugenio GarribbaDipartimento di Chimica e Farmacia, Università di Sassari, via Vienna 2, 07100 Sassari, Italy.ORCID 0000-0002-7229-5966
Massimiliano PeanaDipartimento di Chimica e Farmacia, Università di Sassari, via Vienna 2, 07100 Sassari, Italy.ORCID 0000-0002-3306-0419
Maria Antonietta ZorodduDipartimento di Chimica e Farmacia, Università di Sassari, via Vienna 2, 07100 Sassari, Italy.ORCID 0000-0001-9583-4750
Valeria Marina NurchiDipartimento di Scienze della Vita e dell'Ambiente, Università di Cagliari, 09042 Cagliari, Italy.ORCID 0000-0002-4004-1988

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The good chelating properties of hydroxypyrone (HPO) derivatives towards oxidovanadium(IV) cation, V

Indexed as

DFT calculationsEPR spectroscopyESI-MS spectrometrykojic acidoxidovanadium(IV)potentiometryUV-visible spectrophotometry

Identifiers

PMID34681261
PMCPMC8541509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.